Difference between revisions of "Yousefnia S, et al. Gene (2018) cited as Ref 385 in DOI: 10.1038/s41392-020-0110-5 (Q9648)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Ghaedi K, #quickstatements; #temporary_batch_1590155310798) |
(Created claim: Fifth Author string (P153): Nasr Esfahani MH, #quickstatements; #temporary_batch_1590155508986) |
||
| Property / Fifth Author string | |||
| + | Nasr Esfahani MH | ||
| Property / Fifth Author string: Nasr Esfahani MH / rank | |||
| + | Normal rank | ||
Latest revision as of 13:52, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Yousefnia S, et al. Gene (2018) cited as Ref 385 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Yousefnia S
0 references
Momenzadeh S
0 references
Seyed Forootan F
0 references
2018
0 references
Gene
0 references
649
0 references
The influence of peroxisome proliferator-activated receptor gamma (PPARgamma) ligands on cancer cell tumorigenicity (English)
0 references
14-22
0 references
Ghaedi K
0 references
Nasr Esfahani MH
0 references
